Tumor marker change and response rate in patients with elevated... | Download Table
uIcc stages in correlation with ca19-9 serum levels (median and mean)... | Download Table
The Highest Ever Reported Level of Carbohydrate Antigen 19-9: A Case Report | Al-Khallaf | Journal of Medical Cases
Frontiers | Tumor Burden Score Stratifies Prognosis of Patients With Intrahepatic Cholangiocarcinoma After Hepatic Resection: A Retrospective, Multi-Institutional Study
Cholangiocarcinoma | Nature Reviews Disease Primers
Cancers | Free Full-Text | The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and Benign Periampullary Diseases, a Novel Approach
Frontiers | Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology
New Breakthroughs for Liver Transplantation of Cholangiocarcinoma | SpringerLink
JCM | Free Full-Text | Uses of Inflammatory Markers for Differentiation of Intrahepatic Mass-Forming Cholangiocarcinoma from Liver Abscess: Case-Control Study
Cholangiocarcinoma 2020: the next horizon in mechanisms and management | Nature Reviews Gastroenterology & Hepatology
Frontiers | Importance of Normalization of Carbohydrate Antigen 19-9 in Patients With Intrahepatic Cholangiocarcinoma
![PDF] Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bb127959fd840127d322eb4c0f3133e4069e5c6a/2-Figure1-1.png "PDF] Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population. | Semantic Scholar")
PDF] Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population. | Semantic Scholar
Many Patients With Primary Sclerosing Cholangitis and Increased Serum Levels of Carbohydrate Antigen 19-9 Do Not Have Cholangiocarcinoma - ScienceDirect
PDF) CA 19?9 and CE A are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis | Einar Björnsson - Academia.edu
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology
CA 19-9 as a Marker of Survival and a Predictor of Metastization in Cholangiocarcinoma - FullText - GE - Portuguese Journal of Gastroenterology 2017, Vol. 24, No. 3 - Karger Publishers
![PDF] State of serum markers for detection of cholangiocarcinoma. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c14d81ca234c0d592f2e72050604bd015d1da96f/3-Table3-1.png "PDF] State of serum markers for detection of cholangiocarcinoma. | Semantic Scholar")
PDF] State of serum markers for detection of cholangiocarcinoma. | Semantic Scholar
Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas – A retrospective tumor marker prognostic study - ScienceDirect
Biomarkers of intrahepatic cholangiocarcinoma: diagnosis and response to therapy
Relationship Between CA 19.9 and the Lewis Phenotype: Options to Improve Diagnostic Efficiency | Anticancer Research
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
